
    
      This study will last approximately 19 weeks including 16 infusions total, each one week
      apart. This is to help patients that have developed "Post-Viral Fatigue Syndrome" which can
      include symptoms such as: extreme fatigue, lost of taste, brain fog, and/or seizures.
    
  